Turn Therapeutics (TTRX) Non Operating Income (2024 - 2026)

Turn Therapeutics' Non Operating Income history runs 3 years deep, the most recent figure standing at $275171.0 for Q1 2026.

• In Q1 2026, Non Operating Income rose 387.46% year-over-year to $275171.0; the TTM figure through Mar 2026 stood at $2.8 million (changed N/A YoY), while the FY2025 annual figure was $2.7 million, up 9181.3% from the prior year.
• Non Operating Income for Q1 2026 stood at $275171.0, down from $2.5 million in the prior quarter.
• The five-year high for Non Operating Income was $2.5 million in Q4 2025, with the low at $5827.0 in Q4 2024.
• The 3-year median for Non Operating Income is $32910.5 (2025), against an average of $471001.5.
• Peak annual rise in Non Operating Income reached 42334.19% in 2025, while the deepest fall reached 43.07% in 2025.
• Turn Therapeutics' Non Operating Income stood at $5827.0 in 2024, then jumped by 42334.19% to $2.5 million in 2025, then plunged by 88.87% to $275171.0 in 2026.
• Business Quant data shows TTRX's Non Operating Income at $275171.0 in Q1 2026, $2.5 million in Q4 2025, and $9371.0 in Q3 2025.